Furthermore, CAF enhance vascular permeability and leakage that impede drug penetration into the tumor by different factors such are VEGF, lipoma preferred partner (LPP), and platelet-derived growth factor receptor (PDGFR) [60]. The gene discussed is VEGFA; the disease is lipoma.